Showing results (1741-1750 of 2,276) with videos related to

Sort By:
Pageof 228
Nature|August 9, 2016
Defining CD8+ T cells that provide the proliferative burst after PD-1 therapySe Jin Im, Masao Hashimoto, Michael Y Gerner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2018
Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma TherapyCarmela Passaro, Quazim Alayo, Isabella De Laura, et al.
Physical Review Letters|June 4, 2008
Nuclear structure relevant to neutrinoless double beta decay: 76Ge and 76SeJ P Schiffer, S J Freeman, J A Clark, et al.
Cancer Immunology Research|June 7, 2014
Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockadeZachary A Cooper, Vikram R Juneja, Peter T Sage, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 7, 2025
Lumacaftor inhibits channel activity of rescued F508del cystic fibrosis transmembrane conductance regulatorAdam D Ambrosetti, Zachary J Hagedorn, Taylor R Bono, et al.
Nature|May 3, 2023
Targeting PD-L2-RGMb overcomes microbiome-related immunotherapy resistanceJoon Seok Park, Francesca S Gazzaniga, Meng Wu, et al.
Cell|June 26, 2018
LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint BlockadeWanqiang Sheng, Martin W LaFleur, Thao H Nguyen, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 20, 2019
Updates in Pediatric Pancreatology: Proceedings of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Frontiers in Pediatric Pancreatology SymposiumAmit S Grover, Alvin J Freeman, Maisam Abu-El-Haija, et al.
Science Advances|December 8, 2022
Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivoJames A Torchia, Alexander H Tavares, Laura S Carstensen, et al.
Pageof 228